Procter & Gamble HEALTH CARE — Concentration risk (in percent) increased by 12.5% to $0.09 in Q4 2025 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $0.09 to $0.09. Over 2 years (FY 2022 to FY 2025), HEALTH CARE — Concentration risk (in percent) shows an upward trend with a 76.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase suggests higher vulnerability to specific market disruptions, while a decrease indicates a more diversified and resilient revenue stream.
This metric measures the percentage of total segment revenue derived from a single customer, product line, or geographic...
Standard across consumer goods and pharmaceutical segments to assess revenue stability.
pg_segment_health_care_concentration_risk_in_percent| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.02 | $0.02 | $0.02 | $0.02 | $0.08 | $0.09 | $0.08 | $0.00 | $0.08 | $0.09 | $0.08 | $0.00 | $0.08 | $0.09 |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +300.0% | +12.5% | -11.1% | -100.0% | — | +12.5% | -11.1% | -100.0% | — | +12.5% |
| YoY Change | — | — | — | — | +300.0% | +350.0% | — | — | +0.0% | +0.0% | +0.0% | — | +0.0% | +0.0% |
We use cookies for analytics. See our Privacy and Cookie Policy.